March 04, 2015 10:19 AM ET


Company Overview of Medistem, Inc.

Executive Profile

Thomas E. Ichim Ph.D.

Chief Scientific Officer, Director of Research and Director, Regen BioPharma Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 7 different industries.

See Board Relationships
As of Fiscal Year 2014


Dr. Thomas E. Ichim, also known as Tom, PhD has been the President and Chief Scientific Officer at Medistem, Inc., since October 6, 2012. Dr. Ichim is a Co-founder of bioRASI. Dr. Ichim is the founder of ToleroTech Inc., OncoMune LLC and MedVax Pharma Corp. He has been Director of Research and Chief Scientific Officer of Regen BioPharma Inc. since June 15, 2012. Dr. Ichim serves as the Chief Scientific Officer of bioRASI, LLC. Dr. Ichim has been the Chief Executive Officer ...

Corporate Headquarters

9255 Towne Centre Drive
San Diego, California 92121

United States

Phone: 858-352-7071
Fax: --

Board Members Memberships

President, Chief Scientific Officer and Director
Chief Scientific Officer, Director of Research and Director


BS 1998
University of Waterloo
MS 2003
The University Of Western Ontario

Other Affiliations

Annual Compensation

Total Annual Compensation$120,000

Stocks Options

There is no Stock Options data available.

Total Compensation

Total Annual Cash Compensation$120,000
Total Short Term Compensation$120,000
Total Calculated Compensation$120,000

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Medistem, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at